HSP90AB1 and in situ carcinoma: In the orthotopic BCa models, overexpression of HSP90β via shRNA‐insensitive plasmids fully restored the MTCO1 expression levels and cisplatin resistance in T24‐CIS cells, which had been reduced by HSP90β knockdown (Figure S9A,B, Supporting Information).